✦ LIBER ✦

P01-57 - Analysis of pooled safety data from three randomized, double-blind, placebo-controlled studies of adjunctive aripiprazole in major depressive disorder

✍ Scribed by J.-Y. Loze; R. Gismondi; R. McQuade; W. Carson; R. Berman

Book ID: 119570043
Publisher: Elsevier Science
Year: 2010
Tongue: French
Weight: 32 KB
Volume: 25
Category: Article
ISSN: 0924-9338
DOI: 10.1016/s0924-9338(10)70276-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PW01-20 - Adjunctive aripiprazole in pat

PW01-20 - Adjunctive aripiprazole in patients with major depressive disorder: pooled safety and tolerability data from three short-term studies

✍ Loze, J.-Y.; Gismondi, R.; McQuade, R.; Carson, W.; Berman, R. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 34 KB

P01-38 - Efficacy of adjunctive aripipra

P01-38 - Efficacy of adjunctive aripiprazole in patients with major depressive disorder: pooled analysis of subgroup data from three clinical trials

✍ R. Gismondi; R. McQuade; J.-Y. Loze; R. Owen; R. Berman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 30 KB

ARIPIPRAZOLE IN THE TREATMENT OF SCHIZOA

ARIPIPRAZOLE IN THE TREATMENT OF SCHIZOAFFECTIVE DISORDER: POOLED ANALYSIS FROM TWO RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS

✍ Reza Moghadam; Ira D. Glick; Raymond Mankoski; James M Eudicone; Quyhn-Van Tran; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

P.2.c.031 Safety and tolerability of adj

P.2.c.031 Safety and tolerability of adjunctive aripiprazole in major depressive disorder: pooled data from 3 short-term studies

✍ J.Y. Loze; R. Gismondi; R. McQuade; W. Carson; R. Berman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 189 KB

PW01-11 - Effect of adjunctive aripipraz

PW01-11 - Effect of adjunctive aripiprazole on quality of life in patients with major depressive disorder: pooled data from three clinical trials

✍ Gismondi, R.; Loze, J.-Y.; Baker, R.; Jing, Y.; Corey-Lisle, P.; Rollin, L.; Tra 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 30 KB

Safety and tolerability of duloxetine in

Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials

✍ James I. Hudson; Madelaine M. Wohlreich; Daniel K. Kajdasz; Craig H. Mallinckrod 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

## Abstract ## Objective To examine the safety and tolerability of the antidepressant duloxetine across multiple studies for major depressive disorder (MDD). ## Method Safety data were integrated from the acute phases of eight double‐blind, placebo‐controlled trials in which patients were random